Enliven Therapeutics (ELVN) Net Equity Issued and Repurchased (2019 - 2026)
Enliven Therapeutics (ELVN) recorded Net Equity Issued and Repurchased of $29.59 million in Q2 2026, compared with $1.32 million a year earlier and up 194.3% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
On a TTM basis, Enliven Therapeutics' Net Equity Issued and Repurchased came in at $40.38 million as of Jun 30, 2026; for FY2025, it came in at $2.3 million, down 36.8% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -50.9% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $3.63 million in FY2024 (-97.7%), $161.37 million in FY2023, $591,000 in FY2022 (-31.3%) and $860,000 in FY2021 (-98.9%).
- The Q2 2026 figure is the highest quarterly Net Equity Issued and Repurchased since Q1 2023.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in 1 of the last four quarters, with an average decline of 26.0%.
- Per Business Quant, the preceding three quarters came in at $10.05 million (Q1 2026), $528,000 (Q4 2025) and $209,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Enliven Therapeutics | 3.38 Bn | 3.38 Bn | - | 29.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.59 Mn |
| Mar 31, 2026 | 10.05 Mn |
| Dec 31, 2025 | 528,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 234,000.00 |
| Dec 31, 2024 | 453,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.79 Mn |
| Mar 31, 2024 | 270,000.00 |
| Jun 30, 2023 | -1.54 Mn |
| Mar 31, 2023 | 162.90 Mn |
| Dec 31, 2022 | 13,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 573,000.00 |
| Sep 30, 2021 | 145,000.00 |
| Jun 30, 2021 | 243,000.00 |
| Mar 31, 2021 | 472,000.00 |
| Jun 30, 2020 | 11.02 Mn |
| Mar 31, 2020 | 69.41 Mn |
API Access
Enliven Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();